(14) In that case, Inwood Laboratories manufactured the drug cycladelate and intentionally copied the appearance of Ives Laboratories' trademarked cycladelate drug Cyclospasmol
. (15) Ives sued Inwood, claiming that Inwood's use of look-alike capsules induced pharmacists to mislabel Inwood's drugs in order to pass them off as Cyclospasmol
, thereby infringing Ives's trademark.
Since 1987, Butazolidin has been totally withdrawn from the market, and Vasodilan and Cyclospasmol are no longer mentioned in the Physicians' Desk Reference (PDR).
Even though Butazolidin is no longer available in drugstores, and Cyclospasmol and Vasodilan are virtually unobtainable, the Harvard study credits physicians with prescribing these three drugs more than 500,000 times for older patients in 1994. The explanation for this incongruous statement, of course, lies in the study's 7-year-old database that lingers on, long after these pills vanished from the marketplace.